Clinical trial
Clinical Trial on the Mixture of G, C and S in Treatment of Patients With RCC
NCT00496301 · Spanish Oncology Genito-Urinary Group, Other · Completed
Key facts
| NCT number | NCT00496301 |
|---|---|
| Title | Clinical Trial on the Mixture of G, C and S in Treatment of Patients With RCC |
| Official title | Phase II Clinical Trial, Non-Randomized, Multicentre, on the Combination of Gemcitabine, Capecitabine and Sorafenib (Bay 43-9006) in Treatment of Patients With Unresectable and/or Metastatic Renal Cell Carcinoma (RCC) |
| Acronym | SOGUG-02-06 |
| Lead sponsor | Spanish Oncology Genito-Urinary Group, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Carcinoma, Renal Cell |
| Intervention type | Drug |
| Interventions | Gemcitabine, Capecitabine and Sorafenib (6 cycles) |
| Enrollment | 40 |
| Start date | Nov 1, 2006 |
| Primary completion | Apr 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Jul 4, 2007 |
| Last update posted | Jan 14, 2009 |
| Countries | Spain |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: